Literature DB >> 6501566

Role of phorbol diesters in in vitro murine megakaryocyte colony formation.

M W Long, J E Smolen, P Szczepanski, L A Boxer.   

Abstract

In vitro megakaryocyte differentiation is regulated by two activities: a megakaryocyte colony-stimulating activity (Mk-CSA), which is required for proliferation, and an auxiliary factor, megakaryocyte potentiating activity, which plays a role in later differentiation events. Tumor-promoting phorbol esters alter many cellular differentiation-related events. Thus, it was hypothesized that phorbol esters may bring about megakaryocyte differentiation in vitro. 4 beta-Phorbol 12-myristate 13-acetate (PMA), when co-cultured with a source of Mk-CSA, stimulated a threefold increase in colony numbers. Co-culture of PMA and megakaryocyte potentiator activity did not stimulate colony formation, thus eliminating any action of PMA as an Mk-CSA. The direct effect of PMA on the formation of megakaryocyte colonies was established by (a) the function of PMA as a megakaryocyte potentiator in serum-free experiments, (b) the ability of PMA to stimulate megakaryocyte colony formation using bone marrow cells depleted of populations known to produce potentiating activity, (c) the inability of bone marrow adherent cells previously treated with phorbol, 12,13-dibutyrate (PDBu) to augment megakaryocyte colony formation, and (d) the ability of PMA to induce the growth of immature megakaryocytes into large single megakaryocytes. Structure:activity experiments resulted in equivalent activities for PMA and PDBu, whereas the nontumor promoter phorbol 12,13-diacetate and phorbol itself lacked activity. The observations in this study indicate that phorbol esters can bring about megakaryocyte differentiation, and during colony formation, can induce effects identical to those brought about by biological sources of megakaryocyte potentiator activity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6501566      PMCID: PMC425346          DOI: 10.1172/JCI111585

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  Characteristics of murine megakaryocytic colonies in vitro.

Authors:  S A Burstein; J W Adamson; D Thorning; L A Harker
Journal:  Blood       Date:  1979-07       Impact factor: 22.113

2.  Separation of cells by velocity sedimentation.

Authors:  R G Miller; R A Phillips
Journal:  J Cell Physiol       Date:  1969-06       Impact factor: 6.384

3.  Induction of differentiation in human promyelocytic leukemia cells by tumor promoters.

Authors:  G Rovera; T G O'Brien; L Diamond
Journal:  Science       Date:  1979-05-25       Impact factor: 47.728

4.  Growth of mouse megakaryocyte colonies in vitro.

Authors:  D Metcalf; H R MacDonald; N Odartchenko; B Sordat
Journal:  Proc Natl Acad Sci U S A       Date:  1975-05       Impact factor: 11.205

5.  Regulation of proliferation of murine megakaryocyte progenitor cells by cell cycle.

Authors:  N Williams; H Jackson
Journal:  Blood       Date:  1978-07       Impact factor: 22.113

6.  Preferential inhibition of murine macrophage colony formation by prostaglandin E.

Authors:  N Williams
Journal:  Blood       Date:  1979-06       Impact factor: 22.113

7.  Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines.

Authors:  P Ralph; M A Moore; K Nilsson
Journal:  J Exp Med       Date:  1976-06-01       Impact factor: 14.307

8.  Isolation of intact megakaryocytes from guinea pig femoral marrow. Successful harvest made possible with inhibitions of platelet aggregation; enrichment achieved with a two-step separation technique.

Authors:  R F Levine; M E Fedorko
Journal:  J Cell Biol       Date:  1976-04       Impact factor: 10.539

9.  Complete replacement of serum by albumin, transferrin, and soybean lipid in cultures of lipopolysaccharide-reactive B lymphocytes.

Authors:  N N Iscove; F Melchers
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

10.  Regulation of macrophage and granulocyte proliferation. Specificities of prostaglandin E and lactoferrin.

Authors:  L M Pelus; H E Broxmeyer; J I Kurland; M A Moore
Journal:  J Exp Med       Date:  1979-08-01       Impact factor: 14.307

View more
  7 in total

1.  Regulation of megakaryocyte phenotype in human erythroleukemia cells.

Authors:  M W Long; C H Heffner; J L Williams; C Peters; E V Prochownik
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

2.  Human recombinant granulocyte-macrophage colony stimulating factor and interleukin 3 have overlapping but distinct hematopoietic activities.

Authors:  S G Emerson; Y C Yang; S C Clark; M W Long
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

3.  Synergistic regulation of human megakaryocyte development.

Authors:  M W Long; R J Hutchinson; L L Gragowski; C H Heffner; S G Emerson
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

4.  Characterization of mouse clonogenic megakaryocyte progenitors.

Authors:  Thanyaphong Na Nakorn; Toshihiro Miyamoto; Irving L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-18       Impact factor: 11.205

5.  Phorbol diesters stimulate the development of an early murine progenitor cell. The burst-forming unit-megakaryocyte.

Authors:  M W Long; L L Gragowski; C H Heffner; L A Boxer
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

6.  Unique in vitro and in vivo thrombopoietic activities of ingenol 3,20 dibenzoate, a Ca(++)-independent protein kinase C isoform agonist.

Authors:  Frederick K Racke; Maureen Baird; Rolf F Barth; Tianyao Huo; Weilian Yang; Nilendu Gupta; Michael Weldon; Heather Rutledge
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

7.  Immune regulation of in vitro murine megakaryocyte development. Role of T lymphocytes and Ia antigen expression.

Authors:  M W Long; D N Shapiro
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.